1-6 of 6
Stefano Ulisciani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

Clinical Trials & Observations
Fabio Efficace, Michele Baccarani, Massimo Breccia, Giuliana Alimena, Gianantonio Rosti, Francesco Cottone, Giorgio Lambertenghi Deliliers, Claudia Baratè, Antonella Russo Rossi, Giuseppe Fioritoni, Luigia Luciano, Diamante Turri, Bruno Martino, Francesco Di Raimondo, Melissa Dabusti, Micaela Bergamaschi, Pietro Leoni, Maria Pina Simula, Luciano Levato, Stefano Ulisciani, Dino Veneri, Simona Sica, Alessandro Rambaldi, Marco Vignetti, Franco Mandelli, for GIMEMA
Journal: Blood
Blood (2011) 118 (17): 4554–4560.
https://doi.org/10.1182/blood-2011-04-347575
Published: 2011
Journal Articles

Real-Life Analysis of Dasatinib in Chronic Phase CML Patients Aged > 60 Years Resistant/Intolerant to Imatinib.

Roberto Latagliata, MD, Massimo Breccia, Fabio Stagno, Luigiana Luciano, Antonella Gozzini, MD, Fausto Castagnetti, Mario Annunziata, Silvia De Matteis, Francesco Albano, Stefano Ulisciani, MD, Patrizia Pregno, Raffaele Porrini, Elisabetta Abruzzese, Bruno Martino, Mario Tiribelli, Pellegrino Musto, MD, Paolo Avanzini, Antonella Russo Rossi, Simona Sica, Umberto Vitolo, Enrico Montefusco, Giovanna Rege Cambrin, Felicetto Ferrara, Gianantonio Rosti, Valeria Santini, MD, Fabrizio Pane, Francesco Di Raimondo, M.D., Giuliana Alimena
Journal: Blood
Blood (2009) 114 (22): 2211.
https://doi.org/10.1182/blood.V114.22.2211.2211
Published: 2009
Journal Articles

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

Giovanna Rege-Cambrin, PhD, Stefano Ulisciani, MD, Giovanna Mattioli, MD, Carmen Fava, MD, Emilia Giugliano, BD, Vanessa Brunetto, BD, Enrico Gottardi, BD, Milena Fava, BD, Giuseppe Saglio, MD
Journal: Blood
Blood (2007) 110 (11): 1956.
https://doi.org/10.1182/blood.V110.11.1956.1956
Published: 2007
Journal Articles

FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.

Daniela Cilloni, MD, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Stefano Ulisciani, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Thea Kalebic, MD, Giuseppe Saglio, MD
Journal: Blood
Blood (2007) 110 (11): 1010.
https://doi.org/10.1182/blood.V110.11.1010.1010
Published: 2007
Journal Articles

Development of a Genetic Tool Based on BCR-ABL Transgenic Drosophila Melanogaster for Identification of Genes Involved in CML Progression and Drug Testing.

Daniela Cilloni, MD, PhD, Francesca Messa, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Paolo Nicoli, MD, Emanuela Messa, MD, Stefano Ulisciani, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Thea Kalebic, MD, Michele Baccarani, MD, Fabian Feiguin, MD, PhD, Giuseppe Saglio, MD
Journal: Blood
Blood (2007) 110 (11): 468.
https://doi.org/10.1182/blood.V110.11.468.468
Published: 2007
Journal Articles

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Emilia Giugliano, BD, Dario Ferrero, MD, Carmen Fava, MD, Chiara Dellacasa, MD, Giovanna Mattioli, MD, Patrizia Scaravaglio, BD, Enrico Gottardi, Stefano Ulisciani, MD, Filomena Daraio, BD, Giuseppe Saglio, MD, Giovanna Rege-Cambrin, MD
Journal: Blood
Blood (2006) 108 (11): 4910.
https://doi.org/10.1182/blood.V108.11.4910.4910
Published: 2006